...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Profile of serum pregnancy-associated plasma protein a after sustained subcutaneous low molecular weight heparin administration in patients with cerebrovascular diseases.
【24h】

Profile of serum pregnancy-associated plasma protein a after sustained subcutaneous low molecular weight heparin administration in patients with cerebrovascular diseases.

机译:脑血管疾病患者持续皮下低分子肝素给药后血清妊娠相关血浆蛋白a的概况。

获取原文
获取原文并翻译 | 示例
           

摘要

Pregnancy-associated plasma protein A (PAPP-A), considered a surrogate marker of increased risk of unstable atherosclerosis and its complications (1, 2), is revers-ibly bound to the surfaces of several cell types because of heparin's effective competition for surface binding (3). Heparins, however, especially low molecular weight heparins (LMWH), are routinely used for the treatment and prevention of thromboembolism. Because of the observation that intravenous administration of LMWH and heparin elicits a rapid increase in serum PAPP-A (4), we investigated the time profile of the effect of subcutaneous LMWH administration on PAPP-A concentration in a cerebrovascular disorder population.
机译:妊娠相关血浆蛋白A(PAPP-A)被认为是不稳定动脉粥样硬化及其并发症风险增加的替代标志物(1、2),由于肝素对表面的有效竞争,可逆地与多种细胞类型的表面结合。绑定(3)。然而,肝素,特别是低分子量肝素(LMWH),通常用于治疗和预防血栓栓塞。由于观察到LMWH和肝素的静脉内给药会引起血清PAPP-A的快速增加(4),我们研究了皮下LMWH给药对脑血管疾病人群中PAPP-A浓度影响的时间变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号